Skip to main content

Table 4 Reasons for antibiotic discontinuation

From: Linezolid versus daptomycin treatment for periprosthetic joint infections: a retrospective cohort study

Reasons

Group L, n (%)

Group D, n (%)

P valuea

Continuation for clinical success

17 (44%)

30 (70%)

0.025

Clinical failure or not evaluable

3 (8%)

3 (7%)

1.000

Adverse event

12 (31%)

3 (7%)

0.009

Shift to another antibiotic after identification or for no efficacy

3 (8%)

6 (14%)

0.487

Fixed administration duration in advance

2 (5%)

1 (2%)

0.602

Unknown

2 (5%)

0 (0%)

0.223

  1. n number
  2. aFisherā€™s exact test